Adenoviral conjunctivitis (Ad-CS) has never been so popular a topic as it is right now. With over 26 million viewers tuning in to watch the Olympics, Americans have watched Bob Costas’s unilateral conjunctivitis worsen, then become bilateral. His ocular condition prompted many commentators to remark, “Can’t someone help him?”
Adenoviral conjunctivitis (Ad-CS) has never been so popular a topic as it is right now. With over 26 million viewers tuning in to watch the Olympics, Americans have watched Bob Costas’s unilateral conjunctivitis worsen, then become bilateral. His ocular condition prompted many commentators to remark, “Can’t someone help him?”
Blair Lonsberry, MS, OD, MEd, FAAO, shares highlights from his 2022 American Academy of Optometry presentation, "Simplifying systemic antibiotics."
All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.
Derek Cunningham, OD, FAAO, gives key takeaways from his AAOpt 2022 discussion, "Back to the basics: The importance of treating inflammation AND obstruction for dry eye."
A newer class of topical glaucoma therapy, Rho kinase inhibitors, works to lower intraocular pressure in patients with glaucoma via a novel mechanism. In this podcast, Mitch Ibach, OD, FAAO, of Vance Thompson Vision in Sioux Falls, SD, and Jessica Steen, OD, FAAO, of the Nova Southeastern University College of Optometry in Fort Lauderdale, FL, will discuss the mechanism of action of these agents, along with data supporting their use within the broader range of topical glaucoma therapies.
Enthusiasm regarding the acceleration of technology advances, including retinal monitoring centers, that can be used to help prevent disease progression for patients with eye diseases.
The Contact Lens Institute unveiled a preview of their data on contact lens patient retention at Vision Expo West. The full report will be released later this year.